Thriving in the pharmaceutical landscape: The Economist highlights big pharma's robust growth alongside the resurgence of biotech startups marking an era of exciting opportunities. The recent surge in investments and IPOs underscores #AI advancement that could revolutionize drug discovery. For more: https://econ.st/3V4ZJic #Pharma #Biotech #Innovation
Russo Partners
Public Relations and Communications Services
New York, NY 1,118 followers
Public and investor relations for the innovators in healthcare and technology.
About us
Since our founding in 1988, Russo Partners has been working side by side with innovators and influencers in the healthcare and technology industries. Our evolution in the biopharma and healthcare technology ecosystem is unparalleled as is our network, and the knowledge we bring to our clients is extensive. We bring passion, a culture of excellence, forward thinking and client focus every day to everything we do.
- Website
-
http://www.russopartnersllc.com
External link for Russo Partners
- Industry
- Public Relations and Communications Services
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 1988
- Specialties
- Media Relations, Messaging and Positioning, Investor Relations, Issue and Crisis Management, Clinical Trial Recruitment, Corporate Communications, Online Communications, Regulatory Communications, Professional and Advocacy Relations, and Sports-Health Alliance Offering
Locations
-
Primary
Get directions
12 W 27th Street
4th Floor
New York, NY 10001, US
Employees at Russo Partners
-
Devin A. Brown
Digital Comms in Life Sciences | VP @ Russo Partners | Social & Digital Leader | Growth Marketer | 14-Year McKinsey Alum
-
Tony Russo, Ph.D.
Russo Partners
-
Scott Stachowiak
Health | Pharma | Biotech Communications | Media Relations Expertise and Counsel
-
David Schull
President, Russo Partners, LLC
Updates
-
Russo Partners reposted this
Join Russo Partners President David Schull as he moderates a discussion around the recent uplift in biotech stocks and financings—the best quarter since early 2021. Joining him will be Aaron Schwimmer, Managing Director, Healthcare Bank of America; Harold Tamayo, Vice President of Finance and Investor Relations, axogen; and Brad Prosek, Operating Partner, EcoR1 Capital, LLC. To register for The Association of Bioscience Financial Officers International (ABFO), visit here: https://lnkd.in/gCG2teiM #ABFO2024 #BiotechInvestment #CFO
Show me the money! I will host the main-stage state of the capital markets session at the 2024 ABFO National Conference - May 28 -31, 2024 - Boston. Our line-up is Aaron Schwimmer, Harold D. Tamayo and Brad Prosek. See you in Boston. #biotech #finance #ABFO24
-
-
Join Russo Partners President David Schull as he moderates a discussion around the recent uplift in biotech stocks and financings—the best quarter since early 2021. Joining him will be Aaron Schwimmer, Managing Director, Healthcare Bank of America; Harold Tamayo, Vice President of Finance and Investor Relations, axogen; and Brad Prosek, Operating Partner, EcoR1 Capital, LLC. To register for The Association of Bioscience Financial Officers International (ABFO), visit here: https://lnkd.in/gCG2teiM #ABFO2024 #BiotechInvestment #CFO
Show me the money! I will host the main-stage state of the capital markets session at the 2024 ABFO National Conference - May 28 -31, 2024 - Boston. Our line-up is Aaron Schwimmer, Harold D. Tamayo and Brad Prosek. See you in Boston. #biotech #finance #ABFO24
-
-
Russo Partners reposted this
📰 NEWS: Fantastic to see healthcare professionals praising our "gamechanging" DeepView AI®– Burn technology in the Daily Mail News. ➡️ Read the article –'More accurate at spotting damage than doctors': AI technology could speed up help for burns victims – here: https://lnkd.in/e9XJydzP #burnwounds #predictiveai #betterburncare
-
-
Russo Partners skillfully supported a successful Direct Public Offering (DPO) for a client, highlighting our expertise in strategic communications and investor relations. Our targeted advertising campaign across various financial platforms reached millions, significantly enhancing investor engagement by helping to maintain attention for the company post-DPO. Learn how our integrated approach can support your financial goals: https://bit.ly/3QdODVn #Financing #DPO #CaseStudy
-
-
Catch David Schull in this must-listen podcast as he dives into the exciting world of #biotech and shares invaluable career advice!
Listen Here: https://lnkd.in/gzCtwu63 In this episode, David Schull, President, Russo Partners LLC shares insights into Russo Partners, his excitement surrounding the current biotech boom, his advice for emerging professionals looking to have fulfilling careers, and more. #podcast #businessleadership #leadership Scott Becker Private Equity and Healthcare Podcasts -Scott Becker McGuireWoods LLP Becker's Healthcare Becker Private Equity and Business Podcast
-
-
Russo Partners reposted this
We are thrilled to announce that Axogen’s Vice President of Regulatory Affairs, Angela Nelson, MBA, RAC(GS) has been named a Top 25 Biotechnology Executive for 2024 by The Healthcare Technology Report. It is an honor to have Angela among the prestigious cast of this year’s awardees. The hard work of exemplary professionals like Angela on behalf of patients suffering from peripheral nerve injuries makes a real difference. We are proud to have Angela on our team! https://hubs.la/Q02wxtMs0
-
-
Thrilling developments in the #digitalhealth industry as Q1 of 2024 showcased a remarkable resurgence in funding, driven by several mega-rounds. Despite a record-low in deal counts, the sector saw a substantial 48% growth in investments compared to Q4 of 2023, signaling a robust appetite for innovation. Read more in Law360: https://bit.ly/4dz6Hmw #DigitalHealthFunding #HealthFunding #Dealflow
-
-
Exciting breakthrough for #MS patients! Fox News Media reports on a new study that shows promise for a ‘liquid gold’ medication from Clene Nanomedicine, Inc. CNM-Au8, a drinkable liquid with gold nanocrystals, led to an improvement in MS symptoms including vision, cognition, and balance in a double-blind clinical trial in collaboration with the University of Sydney. Learn more: https://fxn.ws/4dvjB5g #SciComms #MultipleSclerosis
-
-
Fierce Biotech’s reporting reveals a significant surge in M&A deals during the first quarter of 2024, highlighting the robust opportunities for pre-commercial companies and investors alike. Led by oncology-focused biotechs, the trend indicates a dynamic landscape poised for continued growth and innovation. Read more here: https://bit.ly/4dnBzGM #Biopharma #MergersAndAcquisitions #MandA #Innovation
-